Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1
Abstract Farnesoid X receptor (FXR), a nuclear receptor for maintaining bile acid homeostasis, has been recognized as a tumor suppressor in enterohepatic tissues. However, its expression and functional role in non-small cell lung cancer (NSCLC) remain unclear. We report that FXR is significantly inc...
Guardado en:
Autores principales: | Wenjie You, Bi Chen, Xueqing Liu, Shan Xue, Hui Qin, Handong Jiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/32154bc168c64d1389ada3f347e838e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Allosteric modulation of the farnesoid X receptor by a small molecule
por: Matthias Gabler, et al.
Publicado: (2018) -
Molecular tuning of farnesoid X receptor partial agonism
por: Daniel Merk, et al.
Publicado: (2019) -
The human intermediate prolactin receptor is a mammary proto-oncogene
por: Jacqueline M. Grible, et al.
Publicado: (2021) -
The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
por: Johanna Stachelscheid, et al.
Publicado: (2021) -
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
por: Limin Zhang, et al.
Publicado: (2016)